Physician profile
James E Cawley
NPI 1942265871
$1,150.08
in general payments reported to CMS, 2019-2025
17 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $75.04 · 2021: $169 · 2022: $257 · 2023: $380 · 2024: $159 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $314.30 | 2022-2025 | Acessa Provu System, Aptima, Fluent Fluid Management System |
| Amgen INC. | $123.48 | 2021 | |
| Astellas Pharma US INC | $119.82 | 2023-2025 | Veozah |
| Myriad Women'S Health, INC. | $106.91 | 2023 | Myrisk |
| Organon LLC | $80.91 | 2022-2024 | Nexplanon |
| Abbvie INC. | $79.13 | 2020-2021 | |
| Ethicon US, LLC | $60.50 | 2022-2025 | Dermabond Prineo, Stratafix, Enseal X1 |
| Biogen, INC. | $54.39 | 2024 | Vumerity, Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $31.23 | 2023 | Exparel |
| Coopersurgical, INC. | $31.02 | 2022 | |
| Pfizer INC. | $30.32 | 2023-2024 | |
| Exeltis, USA INC. | $28.06 | 2023 | Slynd |
| Allergan, INC. | $24.79 | 2020 | |
| Sumitomo Pharma America, INC. | $17.74 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $16.44 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.19 | 2025 | Mounjaro, Zepbound |
| Medtronic, INC. | $14.85 | 2023 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cawley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.